STAT+: Invitae’s new CEO on why the genetic testing firm stopped chasing ‘volume at all costs’
"The industry is learning that almost unlimited access to capital, chasing testing volume and adding cost on the back end, is not sustainable," said Invitae CEO Ken Knight.
